Coreline N. Burggraaff

Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium

Sally F. Barrington, Gerben J.C. Zwezerijnen, Henrica C. W. de Vet et al. · Journal of Nuclear Medicine · 2020 · 113 citations · Full text

Medicine, Oncology, Radiology +17

Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study

Marie José Kersten, Julia Driessen, Josée M. Zijlstra et al. · Haematologica · 2020 · 102 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)

Pieternella J. Lugtenburg, Peter de Nully Brown, Bronno van der Holt et al. · Journal of Clinical Oncology · 2020 · 86 citations · Full text

Medicine, Oncology, Pharmacotherapy +7

Quantitative implications of the updated EARL 2019 PET–CT performance standards

Andres Kaalep, Coreline N. Burggraaff, Simone Pieplenbosch et al. · EJNMMI Physics · 2019 · 82 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial

Martine E.D. Chamuleau, Coreline N. Burggraaff, Marcel Nijland et al. · Haematologica · 2019 · 53 citations · Full text

Medicine, Oncology, Pharmacotherapy +17